Table 4.
Univariate and multivariate analysis for DFS
| Characteristics | Univariate | Multivariate | ||
|---|---|---|---|---|
| p-Value | HR | 95%CI | p-Value | |
| Age (>50 vs ≤50) | 0.069 | 0.485 | 0.237–0.989 | 0.047 |
| Menopausal status (pre vs post) | 0.765 | |||
| Surgery (mastectomy vs BCS) | 0.334 | |||
| Pathology (IDC vs others) | 0.799 | |||
| Tumors (≤2 cm vs ＞2 cm) | 0.252 | 1.365 | 0.643–2.897 | 0.417 |
| Nodes involved (negative vs positive) | 0.013 | 2.866 | 1.371–5.992 | 0.005 |
| Grade (I-II vs III) | 0.848 | |||
| ER (positive vs negative) | 0.557 | 0.725 | 0.351–1.495 | 0.383 |
| PR (positive vs negative) | 0.591 | 0.837 | 0.276–2.543 | 0.754 |
| Ki67 (≤30% vs ＞30%) | 0.013 | 0.404 | 0.185–0.885 | 0.023 |
| Chemotherapy (EC-T vs others) | 0.721 | |||
| Radiation (yes vs no) | 0.323 | |||
| Endocrine therapy (yes vs no) | 0.910 | |||
| ALC (≥1.8 vs ＜1.8) | 0.014 | 2.723 | 1.211–6.122 | 0.015 |
| NLR (≥1.77 vs＜1.77) | 0.047 | 0.619 | 0.275–1.394 | 0.247 |
| ANC (≥3.2 vs ＜3.2) | 0.645 | |||
Abbreviations: IDC, invasive ductal carcinoma; BCS, breast conserving surgery; ER, estrogen receptor; PR, progestrone receptor; ANC, absolute neutrophil count; ALC, absolute lymphocyte count; NLR, neutrophil to lymphocyte ratio.